Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families. Our scientific approach is based on three core principles: rigorous assessment of genetic targets, engineering brain delivery, and using biomarkers to guide development. Our team thrives in a work environment that is scientifically driven, impact-focused, supportive, and collaborative. Our ability to have a positive impact on people’s lives is directly related to the trust we have in each other and our ability to unify our diverse backgrounds and experience behind our purpose to defeat degeneration.
View Top Employees from Denali Therapeutics| Website | http://www.denalitherapeutics.com |
| Ticker | DNLI |
| Revenue | $129 million |
| Funding | $841.5 million |
| Employees | 489 (489 on RocketReach) |
| Founded | 2015 |
| Address | 161 Oyster Point Blvd, South San Francisco, California 94080, US |
| Phone | (650) 866-8548 |
| Technologies |
HTML,
Twitter,
G Suite
+32 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Business Services General, Business Services, Science and Engineering, Drug Discovery, Neurodegenerative Disease, Genetics, Neurodegeneration, Health Care, Pharmaceuticals, Health Diagnostics, Therapeutics |
| Web Rank | 2 Million |
| Keywords | Rare Disease |
| Competitors | Alector, Intra-Cellular Therapies, Introgen Therapeutics, Inc., NGM Biopharmaceuticals, QUEST PHARMA LIMITED |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541711 Companies, NAICS Code 54171 Companies |
Looking for a particular Denali Therapeutics employee's phone or email?
Denali Therapeutics Questions
The Denali Therapeutics annual revenue was $129 million in 2024.
489 people are employed at Denali Therapeutics.
Denali Therapeutics is based in South San Francisco, California.
The NAICS codes for Denali Therapeutics are [541, 5417, 54, 541711, 54171].
The SIC codes for Denali Therapeutics are [873, 87].
Top Denali Therapeutics Employees
-
22
-
55+
-
View
Tony Estrada
SVP, Head of Discovery Sciences at Denali Therapeutics
South San Francisco, California, United States1 -
ViewPeter Chin
Sr. Vice President and Head of Late-Stage Clinical Development and Medical Affairs at Denali Therapeutics
South San Francisco, CA, US5+4 -
ViewErica Kratz
Senior Vice President, Regulatory Affairs, Head of Development Quality Assurance at Denali Therapeutics
South San Francisco, CA, US22 -
View
Carole Ho
Chief Medical Officer and Head of Development at Denali Therapeutics
South San Francisco, CA, US45+ -
23
-
2
-
View
Cynthia Wong
Senior Vice President, Portfolio Planning and Program Management at Denali Therapeutics
San Francisco, CA, US35
Related Companies
